Cargando…

Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway

Background: Drug resistance is well known as a major obstacle for cancer recurrence and treatment failure, leading to poor survival in pancreatic cancer, which is a highly aggressive tumor. Identifying effective strategies to overcome drug resistance would have a significant clinical impact for pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Chao, Chen, Shiyu, Guo, Yuntao, Sun, Chengyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010981/ https://www.ncbi.nlm.nih.gov/pubmed/29930725 http://dx.doi.org/10.7150/thno.23259

Ejemplares similares

TRIM31 promotes glioma proliferation and invasion through activating NF-κB pathway
por: Zhou, Li, et al.
Publicado: (2019)

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
por: Chen, Liwen, et al.
Publicado: (2018)

TRIM14 promotes endothelial activation via activating NF-κB signaling pathway
por: Huang, Xuan, et al.
Publicado: (2019)

TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT–GSK-3β–β-Catenin Signaling Pathway
por: Chen, Shiyu, et al.
Publicado: (2020)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma
por: Chen, Dong, et al.
Publicado: (2012)

Nucleo-Cytoplasmic Trafficking of TRIM8, a Novel Oncogene, Is Involved in Positive Regulation of TNF Induced NF-κB Pathway
por: Tomar, Dhanendra, et al.
Publicado: (2012)

TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
por: Zhao, Ting-Ting, et al.
Publicado: (2018)

TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway
por: Yang, Weihong, et al.
Publicado: (2018)

Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathway in pancreatic cancer
por: Ji, Daolin, et al.
Publicado: (2020)

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
por: Tong, Hongfei, et al.
Publicado: (2020)

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
por: Liu, Jiangbo, et al.
Publicado: (2014)

Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling
por: Ge, Chenxu, et al.
Publicado: (2022)

Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway
por: Zhang, Bo, et al.
Publicado: (2021)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2019)

Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway
por: Su, Xuan, et al.
Publicado: (2016)

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
por: Ji, Jianxiong, et al.
Publicado: (2020)

TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway
por: Li, Lin, et al.
Publicado: (2023)

ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis
por: Xie, Haina, et al.
Publicado: (2020)

SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-κB Signaling Pathway
por: Xie, Yuankang, et al.
Publicado: (2023)

FOXC1-mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis via NF-κB signaling pathway
por: Wei, Yazhi, et al.
Publicado: (2022)

Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2013)

The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: SINKOVICS, JOSEPH G.
Publicado: (2015)

The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)
por: Sinkovics, Joseph G.
Publicado: (2016)

BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
por: Kuang, Chun-mei, et al.
Publicado: (2017)

Saikosaponin a attenuates hyperlipidemic pancreatitis in rats via the PPAR-γ/NF-κB signaling pathway
por: Feng, Pingping, et al.
Publicado: (2020)

Betulinic Acid Ameliorates the Severity of Acute Pancreatitis via Inhibition of the NF-κB Signaling Pathway in Mice
por: Zhou, Ziqi, et al.
Publicado: (2021)

TNFR2 promotes pancreatic cancer proliferation, migration, and invasion via the NF-κB signaling pathway
por: Gao, Zetian, et al.
Publicado: (2023)

Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer
por: Jung, H, et al.
Publicado: (2015)

NF-κB Signaling Pathway Confers Neuroblastoma Cells Migration and Invasion Ability via the Regulation of CXCR4
por: Zhi, Yunlai, et al.
Publicado: (2014)

Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer
por: Li, Zequn, et al.
Publicado: (2020)

Manipulation of Non-canonical NF-κB Signaling by Non-oncogenic Viruses
por: Struzik, Justyna, et al.
Publicado: (2018)

RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway
por: Chen, Shiyu, et al.
Publicado: (2022)

TRIM27 interacts with Iκbα to promote the growth of human renal cancer cells through regulating the NF-κB pathway
por: Xiao, Chengwu, et al.
Publicado: (2021)

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
por: Xiang, Yukai, et al.
Publicado: (2018)

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer
por: Li, Wenbin, et al.
Publicado: (2020)

RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway
por: Zhang, Zhiqi, et al.
Publicado: (2022)

TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
por: Fan, Ming-De, et al.
Publicado: (2020)

TRIM38 protects H9c2 cells from hypoxia/reoxygenation injury via the TRAF6/TAK1/NF-κB signalling pathway
por: Lu, Zhengri, et al.
Publicado: (2022)

TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling
por: Tan, Shu-Tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lus2d0qo3bgvgp8o28lhphdog0